# Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

> **NCT03717454** · NA · UNKNOWN · sponsor: **Zhebao Wu** · enrollment: 50 (estimated)

## Conditions studied

- Prolactinoma

## Interventions

- **OTHER:** Surgery
- **DRUG:** Drug treatment

## Key facts

- **NCT ID:** NCT03717454
- **Lead sponsor:** Zhebao Wu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-01-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03717454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03717454, "Dopamine D2 Receptors(D2R) Imaging in Prolactinomas". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03717454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*